Orphan Technologies actively seeks in-licensing and acquisitions opportunities. We are looking to expand our pipeline with new innovative products targeting rare and ultra-rare diseases. We welcome early stage concepts and established clinical programs, as well as small molecules and biological products.

If you are interested in exploring potential collaborative opportunities with us, please contact us at-